Activity of Estrogen Receptor β Agonists in Therapy-Resistant Estrogen Receptor-Positive Breast Cancer

BACKGROUND: Among women, breast cancer is the leading cause of cancer-related death worldwide. Estrogen receptor α-positive (ERα+) breast cancer accounts for 70% of all breast cancer subtypes. Although ERα+ breast cancer initially responds to estrogen deprivation or blockade, the emergence of resist...

Descripción completa

Detalles Bibliográficos
Autores principales: Datta, Jharna, Willingham, Natalie, Manouchehri, Jasmine M., Schnell, Patrick, Sheth, Mirisha, David, Joel J., Kassem, Mahmoud, Wilson, Tyler A., Radomska, Hanna S., Coss, Christopher C., Bennett, Chad E., Ganju, Ramesh K., Sardesai, Sagar D., Lustberg, Maryam, Ramaswamy, Bhuvaneswari, Stover, Daniel G., Cherian, Mathew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097292/
https://www.ncbi.nlm.nih.gov/pubmed/35574319
http://dx.doi.org/10.3389/fonc.2022.857590

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9097292/
https://www.ncbi.nlm.nih.gov/pubmed/35574319
http://dx.doi.org/10.3389/fonc.2022.857590

Ejemplares similares